Navigation Links
Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
Date:10/14/2008

Former Director of the Office of National Drug Control Policy to Moderate

First Educational Webinar: When Good Medicines Become Bad Drugs

FRAZER, Pa., Oct. 14 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it is embarking on a national educational program designed to promote greater awareness among patients, caregivers and the public about the importance of appropriate and responsible use of prescription opioid medications. The initiative, When Good Medicines Become Bad Drugs(SM), will include a series of free educational programs on timely topics. The first webcast, moderated by General Barry R. McCaffrey, former Director of the Office of National Drug Control Policy, will take place on Tuesday, October 21, 2008, from 3:00 p.m. - 4:00 p.m. Eastern, and will focus on safeguarding medications in the home.

"This program is consistent with Cephalon's commitment to ensure that prescription medications are used safely by the appropriate patients," said Dr. Lesley Russell, Executive Vice President and Chief Medical Officer at Cephalon. "Currently, 71 percent of people who abuse prescription pain medicines received them from a friend or family member, not through a doctor's prescription. The aim of this program is to heighten patient and public awareness of, and responsibility for, safeguarding the use of these important medications."

About When Good Medicines Become Bad Drugs Webcast

This free webcast will provide practical tips about what patients, caregivers and the public can do to safeguard medications and help prevent abuse and diversion of prescription opioids. The webcast will take place on October 21, 2008, from 3:00 p.m. - 4:00 p.m. Eastern. Participants can register at http://video.webcasts.com/events/vxmd001/28151/.

Panelists will include:

Moderator: General Barry R. McCaffrey, former Director of the Off
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ewswire-Asia/ -- The pharma and biotech sectors ar...anies are facing significant,pressure to change wi... calls for,lower prices and a greater regulatory b...l crisis have made the work of creating new drugs ... being forced to globalize their R&D,operation...
(Date:11/9/2009)...RNewswire/ -- Following the provision of clinical,...stration (FDA), privately,owned UK company Daval I...al.com ) has been informed that its innovative,ant...n Orphan-Drug,designation for the treatment of Amy...also known as Lou Gehrig,s disease, is the most co...
(Date:11/6/2009)...RNewswire-FirstCall/ -- BioSpecifics Technologies ...y developing first-in-class collagenase-based prod...e third quarter ended September 30, 2009. ,, "... year, the FDA,s Arthritis Advisory Committee unan...al of XIAFLEX(TM) for the treatment of Dupuytren,s...
(Date:11/6/2009)...v. 6 Calbiotech, Inc. announced to...vative Research (SBIR) Phase I contract by the U.S...r terms of the agreement, Calbiotech will develop ... of Dengue virus. ,, Dengue virus is a mosqu... to military forces deployed to tropical areas of ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...b3c newswire /  - Rentschler Biotechnologie a... biopharmaceutical development and production, hav...operation will enable Rentschler Biotechnologie&rs...im’s large-scale mammalian biopharmaceutical...ce versa, Boehringer Ingelheim’s clients to ...
...rapeutics (Prime), a,thought leader in pharmacy be...ived accreditation from the National Association o...fied Internet Pharmacy Practice,Sites(TM) (VIPPS(R...tablished by NABP in response to,consumers, concer...he,Internet. VIPPS accreditation further authentic...
...stems, Inc., a,privately held company that manufac...nnounced today the newest installation of the PEM ... P.C. in Rockville Centre, New York.,This installa...een Naviscan,and the operators of Rockville PET Im...ging technology to multiple centers throughout the...
Other Biology Technology:Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim 2Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim 3Prime Therapeutics Receives VIPPS Accreditation 2Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 2Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 3
(Date:11/9/2009)...the Netherlands, November 09, 2009 / b3c newswire...ization, and Seventh Wave, an American organizatio...that the companies have signed a letter of intent ...tinal models TIM. The letter of intent proposes a ...o TIM systems for commercialization in North Ameri...
(Date:11/9/2009)...ELPHIA Scientists and industry leaders from aroun..., for the AACR-NCI-EORTC Molecular Targets and Can...ill feature groundbreaking information on importan... a complex disease and to treat it effectively we ...takes place at the molecular level," said Lewis Ca...
(Date:11/8/2009)...T LAFAYETTE, Ind. - Researchers at Purdue Universi...maged nerve fibers in spinal cord injuries using n...shortly after an accident. , The synthetic "copo... nanometers in diameter, or roughly 100 times smal...earchers have been studying how to deliver drugs f...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Depression May Lead to More Preemies Among Blacks 49006 1Depression May Lead to More Preemies Among Blacks 49006 2Good news for some hard to treat hepatitis C patients 49004 1Good news for some hard to treat hepatitis C patients 49004 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 1Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 3
...mmals React to Underwater Sound , Connie Barclay,...ries Service is looking at how marine mammals reac...ts that exposure to intense underwater sound in so...rand and ultimately die. Some of these strandings ...itary sonar, and most have involved beaked whales;...
... newly sequenced genome of a one-celled, planktoni...14) in the journal Nature, is already telling scie...nied the jump from one-celled life forms to multic...aper and a complementary Science paper also releas...biologists Nicole King, Daniel Rokhsar and their c...
...vast and far-reaching as the worlds oceans are, ev...es, according to a study in the journal Science by...t Chapel Hill and others. , The international tea...ects of global change from overfishing to global ...ems, such as coral reefs and continental shelves. ...
Other Biology News:NOAA science story tips -- AAAS 2008 edition 2NOAA science story tips -- AAAS 2008 edition 3NOAA science story tips -- AAAS 2008 edition 4NOAA science story tips -- AAAS 2008 edition 5NOAA science story tips -- AAAS 2008 edition 6NOAA science story tips -- AAAS 2008 edition 7Genome of marine organism tells of humans' unicellular ancestors 2Genome of marine organism tells of humans' unicellular ancestors 3Genome of marine organism tells of humans' unicellular ancestors 4First map of threats to marine ecosystems shows all the world's oceans are affected 2
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...ct measuring instrument for calibrating single-cha...ompact design and the robust carrying case, the MC... laboratory and on-site at the users premises. The...ual channels are tested automatically. Multi-chann...
...tol DTT White solid.. PACKAGED UNDER INERT GAS. ...action is "driven" to completion. A protective age... found in many other preparations. Blocks the leth... ≥97% by titration. Contaminants: Heavy metal...
Biology Products: